DR
Dr Agarwals Eye Hospital Ltd (DRAGARWQ)
₹5,215.00
Mkt cap
₹2,596 Cr
P/E ratio
34.10
P/B
7.27
Div yield
0.13%
ROE
25.20%
ROCE
17.40%
EPS (TTM)
₹152.93
Book value
₹717
52W range
58–6,060
Sector
Healthcare
Price history
Previous close
Dr Agarwal's Eye Hospital Ltd is a leading chain of eye hospitals with predominant presence in Tamil Nadu. [1]
NSE DRAGARWQBSE 526783
Health check
Constructive
ValuationCheap
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−13.94% from high₹5,215
₹58+8,891.38% from low₹6,060
Current
₹5,215.00
Prev close
₹5,159.00
Day
+1.09%
Price performance
1D
+1.76%
1W
+0.79%
1M
−3.14%
3M
+5.01%
6M
—
1Y
—
YTD
+8.92%
Financials
Revenue, profit & margin
P/E ratio
34.1×
DRAGARWQ is 32% below the sector median of 49.8×
DRAGARWQ34.1×
Sector median49.8×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 79 | 84 | 76 | 81 | 100 | 102 | 95 | 100 | 117 | 118 | 116 | 120 | 143 | |
| Expenses | 56 | 61 | 55 | 56 | 69 | 72 | 69 | 68 | 80 | 78 | 82 | 86 | 100 | |
| Operating Profit | 23 | 23 | 21 | 24 | 31 | 30 | 26 | 32 | 37 | 40 | 34 | 34 | 43 | |
| OPM % | 29% | 28% | 27% | 30% | 31% | 29% | 27% | 32% | 32% | 34% | 30% | 28% | 30% | |
| Other Income | 0 | 1 | 1 | 2 | 0 | 2 | 2 | 0 | 1 | 1 | 3 | 2 | 2 | |
| Interest | 2 | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 4 | 4 | 2 | 2 | 3 | |
| Depreciation | 6 | 6 | 7 | 8 | 10 | 9 | 10 | 10 | 11 | 11 | 12 | 12 | 11 | |
| Profit before tax | 16 | 17 | 13 | 17 | 19 | 19 | 14 | 19 | 23 | 26 | 23 | 21 | 31 | |
| Tax % | 26% | 24% | 26% | 26% | 25% | 26% | 26% | 14% | 26% | 25% | 26% | 24% | 24% | |
| Net Profit | 12 | 13 | 9 | 13 | 14 | 14 | 10 | 16 | 17 | 19 | 17 | 16 | 23 | |
| EPS in Rs | 24.55 | 26.79 | 20.09 | 27.21 | 30.02 | 30.11 | 22.13 | 34.02 | 36.72 | 39.98 | 35.76 | 33.60 | 48.38 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202672.67%Promoter
Promoters72.67%
FIIs2.24%0.04
DIIs2.05%0.07
Public23.03%0.04
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,944.50 | 61.14 | 1,28,608 | 0.22% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Max Healthcare | ₹1,049.30 | 68.21 | 1,02,129 | 0.19% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| Manipal Health | ₹738.95 | 109.77 | 97,200 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Fortis Health. | ₹886.00 | 62.70 | 66,889 | 0.11% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Aster DM Quality | ₹755.05 | 182.35 | 65,816 | 0.40% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Global Health | ₹1,499.40 | 70.41 | 40,315 | 0.03% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Narayana Hrudaya | ₹1,928.50 | 45.72 | 39,411 | 0.23% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| Dr Agarwal's Eye | ₹5,371.50 | 34.06 | 2,596 | 0.13% | 23 | +35.46% | 143 | +22.28% | 17.36% |
| Median: 30 Co. | ₹431.67 | 49.80 | 6,085 | 0.01% | 31 | +18.98% | 406 | +22.28% | 14.71% |
Filings
Annual reports15
Concall transcripts1
Credit ratings6
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 10 Sep - AGM on Sep 9 approved Rs4 dividend, audited accounts, director reappointment, and remuneration revisions.Shareholder Meeting / Postal Ballot-Outcome of AGM 9 SepAnnouncement under Regulation 30 (LODR)-Press Release / Media Release 27 Aug - World’s first dedicated Pinhole Pupilloplasty Centre launched in Chennai on August 27, 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Aug - Newspaper Advertisement published for the 32nd Annual General Meeting is submitted.32Nd Annual General Meeting Of The Members Of The Company- September 09, 2026 14 Aug





